Idéal Investisseur
Français English
CAC 40 :
8 157,82 pts
-0.84%


Last updated : 24/04/2026 - 17h35 (last close)
Last close data
🏠 Home   ➤    Stock news

Emeis Reports Increased Revenue in the First Half of 2025

Emeis announced a 6.2% organic revenue growth in the first half of 2025, with particularly strong sales in nursing homes and internationally.


Emeis Reports Increased Revenue in the First Half of 2025

Strong Performance in Key Sectors

In the first half of 2025, Emeis achieved a 6.2% organic increase in revenue. Nursing homes outperformed with a growth of 8.6%, while international activities saw an 8.1% increase. EBITDAR rose by 19.5% on a like-for-like basis, supported by growth in Northern Europe and France. EBITDA, excluding IFRS 16, saw a significant rise of 79% on a like-for-like basis. Net operating cash flow reached 62 million euros, up by 74 million euros from the previous period. Free cash flow turned positive, reaching 26 million euros, an improvement of 204 million euros compared to the previous year.

Exceeding Divestment Targets

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

Emeis exceeded its divestment targets, with 2.1 billion euros of sales completed or secured since mid-2022, including 931 million euros received. Of these sales, 273 million euros were realized since the start of 2025. The group secured 1.16 billion euros from divestments, including 761 million euros through a real estate partnership finalized in September. The group's net debt remained stable at 4,468 million euros as of June 30, 2025, incorporating the impact of ongoing divestments. The net debt to EBITDA ratio improved to 15.4x, from 19.5x at the end of December 2024.

2025 Objectives Confirmed

Emeis confirmed its objectives for 2025, anticipating an EBITDAR increase of 15% to 18% on a like-for-like basis. The average annual revenue growth rate is expected to be between 4% and 5% over the 2024-2028 period, with a similar growth rate for EBITDAR. The group announced the creation of a real estate investment trust for its activities in Europe, aiming to reduce net debt by 700 million euros. Additionally, Emeis became a Mission-driven Company in June 2025, reinforcing its commitment to an inclusive and sustainable societal project.



Sector Santé · Etablissements de santé / EHPAD Etablissements de santé


Assurance vie

Context

Period
  • Period: 9M 2025
Guidance from the release
  • Croissance organique soutenue (+6,4% à fin septembre 2025, +7,0% au T3), amélioration notable des taux d'occupation, objectifs de cessions dépassés (2,1 Md€) et confirmation des perspectives 2025 et de la trajectoire 2024-2028.
Risks mentioned
  • Risques et incertitudes liés aux conditions de marché futures pouvant affecter les résultats prévisionnels
  • Risque de non-réalisation ou de délai des cessions actuellement sécurisées ou en négociation
  • Impact transitoire des ouvertures récentes sur les taux d'occupation dans certaines zones
Opportunities identified
  • Croissance démographique des plus de 75 ans (+30% d'ici 10 ans) créant une demande structurelle accrue
  • Déficit structurel d'offre (déficit attendu de lits sur principaux marchés) offrant une forte visibilité commerciale
  • Possibilités de capture d'effets prix favorables et d'amélioration de marges opérationnelles

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit